Sensitivity and specificity of SARS-CoV-2 S1 subunit in COVID-19 serology assays
Open Access
- 27 October 2020
- journal article
- letter
- Published by Springer Science and Business Media LLC in Cell Discovery
- Vol. 6 (1), 1-4
- https://doi.org/10.1038/s41421-020-00224-3
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (31722020)
- Shanghai Jiao Tong University
- Science and Technology Commission of Shanghai Municipality (20JC1410200)
This publication has 17 references indexed in Scilit:
- Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktailScience, 2020
- Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B CellsCell, 2020
- Cross-neutralization ofSARS-CoV-2 by a human monoclonal SARS-CoV antibodyNature, 2020
- A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2Science, 2020
- Serology assays to manage COVID-19Science, 2020
- Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent IndividualsImmunity, 2020
- Human neutralizing antibodies elicited by SARS-CoV-2 infectionNature, 2020
- A new coronavirus associated with human respiratory disease in ChinaNature, 2020
- A pneumonia outbreak associated with a new coronavirus of probable bat originNature, 2020
- From SARS to MERS, Thrusting Coronaviruses into the SpotlightViruses, 2019